Literature DB >> 7463327

Nasal absorption of propranolol from different dosage forms by rats and dogs.

A Hussain, S Hirai, R Bawarshi.   

Abstract

The blood levels of propranolol in rats and dogs were compared after the administration of nasal, intravenous, and oral solutions. The results indicate that the blood drug levels after nasal and intravenous administration were identical, but the oral administration resulted in considerably lower blood levels. Sustained-release formulations of the drug also were administered nasally and resulted in low initial but prolonged blood levels. The bioavailability of the sustained-release formulation was identical to that of the intravenous administration.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7463327     DOI: 10.1002/jps.2600691215

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

1.  Enhancement of the systemic and CNS specific delivery of L-dopa by the nasal administration of its water soluble prodrugs.

Authors:  H D Kao; A Traboulsi; S Itoh; L Dittert; A Hussain
Journal:  Pharm Res       Date:  2000-08       Impact factor: 4.200

2.  The molecular weight dependence of nasal absorption: the effect of absorption enhancers.

Authors:  M D Donovan; G L Flynn; G L Amidon
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

3.  Absorption of polyethylene glycols 600 through 2000: the molecular weight dependence of gastrointestinal and nasal absorption.

Authors:  M D Donovan; G L Flynn; G L Amidon
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

4.  Correlation between nasal membrane permeability and nasal absorption rate.

Authors:  Hefei Zhang; Chih-Wei Lin; Maureen D Donovan
Journal:  AAPS PharmSciTech       Date:  2012-12-07       Impact factor: 3.246

5.  Pharmacokinetic comparison between the long-term anesthetized, short-term anesthetized and conscious rat models in nasal drug delivery.

Authors:  Yin Cheong Wong; Shuai Qian; Zhong Zuo
Journal:  Pharm Res       Date:  2014-02-20       Impact factor: 4.200

6.  Pharmacokinetic evaluation of formulated levodopa methyl ester nasal delivery systems.

Authors:  Yeon Hong Lee; Kyung Hee Kim; In Kyung Yoon; Kyung Eun Lee; In Koo Chun; Jeong Yeon Rhie; Hye Sun Gwak
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-12-21       Impact factor: 2.441

7.  Enhancement of nasal delivery of a renin inhibitor in the rat using emulsion formulations.

Authors:  T T Kararli; T E Needham; G Schoenhard; D A Baron; R E Schmidt; B Katz; B Belonio
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

Review 8.  Overview of inhalation toxicology.

Authors:  M A Dorato
Journal:  Environ Health Perspect       Date:  1990-04       Impact factor: 9.031

9.  Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration.

Authors:  Rana Rais; Krystyna Wozniak; Ying Wu; Minae Niwa; Marigo Stathis; Jesse Alt; Marc Giroux; Akira Sawa; Camilo Rojas; Barbara S Slusher
Journal:  PLoS One       Date:  2015-07-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.